Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar skat5 (91.41) Submitted: 10/10/2011 1:40:01 PM : Outperform Start Price: $36.29 GILD Score: +29.23

eva momentum value

Report this Post Reply

Featured Broker Partners


Advertisement